These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8069575)

  • 41. Distribution of liposomes containing mannobiose esters of fatty acid in rats.
    Yachi K; Kikuchi H; Yamauchi H; Hirota S; Tomikawa M
    J Microencapsul; 1995; 12(4):377-88. PubMed ID: 8583312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether.
    Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of matrix lipid chain length on liposomes containing cholesterol and ganglioside GM1: implications in drug delivery.
    Bedu-Addo FK; Huang L
    J Pharm Sci; 1996 Jul; 85(7):714-9. PubMed ID: 8818995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of long-term Intralipid administration in mice.
    Allen TM; Murray L
    Can J Physiol Pharmacol; 1986 Jul; 64(7):1006-10. PubMed ID: 3768791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
    Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
    Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel long-circulating liposomes containing peptide library-lipid conjugates: synthesis and in vivo behavior.
    Riché EL; Erickson BW; Cho MJ
    J Drug Target; 2004 Jul; 12(6):355-61. PubMed ID: 15545085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design of liposomes for circumventing the reticuloendothelial cells.
    Mumtaz S; Ghosh PC; Bachhawat BK
    Glycobiology; 1991 Nov; 1(5):505-10. PubMed ID: 1726577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.
    Woodle MC; Matthay KK; Newman MS; Hidayat JE; Collins LR; Redemann C; Martin FJ; Papahadjopoulos D
    Biochim Biophys Acta; 1992 Apr; 1105(2):193-200. PubMed ID: 1586658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting of teniposide to the mononuclear phagocytic system (MPS) by incorporation in liposomes and submicron lipid particles; an autoradiographic study in mice.
    Liliemark E; Sjöström B; Liliemark J; Peterson C; Kållberg N; Larsson BS
    Leuk Lymphoma; 1995 Jun; 18(1-2):113-8. PubMed ID: 8580812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats.
    Liu D; Liu F; Song YK
    Pharm Res; 1995 Apr; 12(4):508-12. PubMed ID: 7596984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid A compared with empty liposomes.
    Allen TM; Murray L; Alving CR; Moe J
    Can J Physiol Pharmacol; 1987 Feb; 65(2):185-90. PubMed ID: 2436731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolongation of liposome circulation time by various derivatives of polyethyleneglycols.
    Yuda T; Maruyama K; Iwatsuru M
    Biol Pharm Bull; 1996 Oct; 19(10):1347-51. PubMed ID: 8913510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
    Allen TM; Hansen C
    Biochim Biophys Acta; 1991 Sep; 1068(2):133-41. PubMed ID: 1911826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications.
    Tilcock C; Ahkong QF; Fisher D
    Biochim Biophys Acta; 1993 May; 1148(1):77-84. PubMed ID: 8499472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposome clearance from blood: different animal species have different mechanisms.
    Liu D; Hu Q; Song YK
    Biochim Biophys Acta; 1995 Dec; 1240(2):277-84. PubMed ID: 8541299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes.
    Chonn A; Semple SC; Cullis PR
    J Biol Chem; 1992 Sep; 267(26):18759-65. PubMed ID: 1527006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomes.
    Dave J; Patel HM
    Biochim Biophys Acta; 1986 Sep; 888(2):184-90. PubMed ID: 3741891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes.
    Unezaki S; Maruyama K; Ishida O; Takahashi N; Iwatsuru M
    J Drug Target; 1993; 1(4):287-92. PubMed ID: 8069570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies of the organ distribution in mice of teniposide liposomes designed for treatment of diseases in the mononuclear phagocytic system.
    Liliemark E; Liliemark J; Kållberg N; Björkholm M; Sjöström B; Peterson C
    Pediatr Res; 1995 Jul; 38(1):7-10. PubMed ID: 7478800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liposome disposition in vivo. III. Dose and vesicle-size effects.
    Abra RM; Hunt CA
    Biochim Biophys Acta; 1981 Dec; 666(3):493-503. PubMed ID: 7034780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.